United States Federal Circuit

In a dispute arising from the rejection of three patent applications relating to controlled-release tablets containing oxymorphone, judgment of the Board of Patent Appeals and Interferences is affirmed in part and vacated in part where decision of obviousness regarding applications was supported by substantial evidence in one instance but lacked evidentiary support with regards to the final two applications.

Appellate Information

• Decided 05/13/2011
• Published 05/13/2011

Judges

• LINN

Court

• United States Federal Circuit

Counsel